Hum. Reprod. Advance Access originally published online on April 21, 2007
Human Reproduction 2007 22(7):2025-2028; doi:10.1093/humrep/dem096
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vaginoplasty using autologous in vitro cultured vaginal tissue in a patient with Mayer–von-Rokitansky–Küster–Hauser syndrome
1 Department of Gynaecology, Obstetrics and Perinatology, University of Rome "La Sapienza", V.le Regina Elena, 324, 00161 Rome, Italy 2 Department of Experimental Medicine, University Sapienza, V.le Regina Elena, 324, 00161 Rome, Italy
3 Correspondence address. Tel: +39-3483410486; Fax: +39-06-49972615; E-mail: pierluigi.benedettipanici{at}uniroma1.it
| Abstract |
|---|
|
|
|---|
Mayer–von-Rokitansky–Küster–Hauser syndrome (MRKHS) is characterized by vaginal agenesis with variable Müllerian duct abnormalities. The Abbè–McIndoe technique is considered a valid treatment option for vaginoplasty but no consensus has been reached on what material should be used for the neovagina canal wall lining. We report the first case of autologous vaginal tissue transplantation in a 28-year-old women with MRKHS. The patient was subjected to a 1 cm2 full-thickness mucosal biopsy from the vaginal vestibule. Following enzymatic dissociation, cells were inoculated onto collagen IV-coated plates and cultured for 2 weeks. The patient was subjected to a vaginoplasty with a modified Abbè–McIndoe vaginoplasty with 314 cm2 autologous in vitro cultured vaginal tissue for the canal lining. At 1 month from surgery, the vagina appeared normal in length and depth and a vaginal biopsy revealed normal vaginal tissue. The use of autologous in vitro cultured vaginal tissue to create a neovagina appears as an easy, minimally invasive and useful method.
Key words: autologous transplant/Mayer–von-Rokitansky–Küster–Hauser syndrome/vaginoplasty
| Introduction |
|---|
|
|
|---|
Mayer–Rokitansky–Küster–Hauser syndrome (MRKHS) (Mayer, 1829
The creation of the vagina can be accomplished over prolonged periods by progressive dilatation with coitus (D'Alberton and Santi, 1972
) or using graduated dilators (Frank, 1938
); however, most physicians report using surgery. Several surgical techniques have been developed for the creation of the neovagina (Baldwin, 1904
; William, 1964; Vecchietti, 1965
; Burger et al., 1989
, Fedele et al., 1994
; Hendren and Atala, 1994
), but most authors adopt the Abbè–McIndoe vaginoplasty (Abbè, 1898; McIndoe and Banniser, 1938
). The procedure consists in the creation of a canal in the potential neovaginal space that is subsequently covered by a full-thickness skin graft. Several variations regarding the material adopted for the canal lining have been proposed (Davydov and Zhvitiashvili, 1974
; Dhall, 1984
; Ashworth et al., 1986
; Jackson and Rosenblatt, 1994
; Templemen and Hertweck, 2000).
We present the first case in which in vitro autologous vaginal cell cultures obtained from biopsies from the vaginal vestibule were used for the epithelization of the neovaginal walls.
| Case report |
|---|
|
|
|---|
A 28-year-old woman was referred to our department for sexual dysfunction and infertility. Gynaecologic history revealed primary amenorrhoea for which she had never sought medical attention. The woman exhibited normal secondary sexual characteristics, hormonal analyses were within normal ranges and her karyotype was 46, XX. Pelvic examination revealed a vaginal agenesis. Ultrasound examination and MRI revealed the agenesis of the uterus and of the left adnexa (atypical MRKHS) (Schmid-Tannwald and Hauser, 1977
|
Following enzymatic dissociation, the keratinocyte suspension was inoculated onto four collagen IV (10 µg/ml)-coated culture plates. Cells were seeded at cell density of 2.5 x 105 cells/plate and maintained in chemical defined medium MCDB 153 (EpiLife, Cascade Biologics, Inc., Portland, OR, USA) with medium change twice a week. After a week of culture, cells reached 70–80% of confluency (Fig. 2a and b inset) being cultured for additional 8 days in order to obtain the fully differentiated mucosal tissue (Fig. 2c and d inset). Autologous reconstructed vaginal tissues reached 314 cm2 when they were harvested from the culture plates by incubation with dispase II (2.5 mg/ml) (Fig. 2e), washed in PBS and mounted on 2 mg/10 cm2 hyaluronic acid embedded gauze to maintain the orientation of the mucosal tissue and transferred to the operative theatre (Fig. 2f and g).
|
Before surgery, the patient was treated with antibiotics prophylaxis and a bowel enema. In the operative room, the patient was placed in a lithotomic position with a Foley catheter. A midline incision at the vaginal introitus was made, and a 10 cm canal was made between the bladder and the rectum using a blunt digital and scissor dissection reaching the pouch of Douglas (Fig. 3a). Complete haemostasis was obtained with electrocautery. The tunnel was covered with the gauze with the cell stratum facing the canal walls (Fig. 3b). A 2 cm in diameter and 12 cm in length vaginal mould covered by a condom was placed in the neovagina. The mould was fixed to the perineum with stitches bilaterally. No stitches were used to keep the gauze in place. Operation time was 18 min. Estimated blood loss was <100 ml. The gauze, the Foley catheter and the mould were kept in place for 5 post-operative days. At this point the estimate percentage of take was over 90%. The patient was instructed to wear at night the vaginal mould for the successive 6 weeks. Colposcopy and a vaginal biopsy confirmed normal epithelium (Fig. 4). At four months of follow-up, no stricture, no foul-smelling vaginal discharge or sensation of vaginal dryness was reported and sexual intercourse was referred by both partners as satisfactory.
|
|
| Conclusions |
|---|
|
|
|---|
This is the first case of in vitro cultured autologous vaginal tissue transplantation. The ideal treatment of the MRKHS remains a matter of debate. Although non-surgical techniques for the creation of a neovagina (D'Alberton and Santi 1972
A valid alternative for the creation of the neovagina is the Abbè–McIndoe vaginoplasty. This consists in the creation of a vaginal canal created by dissecting the potential neovaginal space, which is then subsequently covered by a skin graft (Abbè, 1898; McIndoe and Banniser, 1938
). The main disadvantages connected with this procedure are the surgical complexity and the scar that remains in the donor site.
Several modifications of this technique, especially regarding the material adopted for the canal lining, have been proposed. These include the use of the peritoneum (Rotman, 1972; Davydov and Zhvitiashvili, 1974
), the amnion (Dhall, 1984
; Templeman et al., 2000), allogenic epidermal sheets (Carranza-Lira et al., 1999
), Interceed (Jackson and Rosenblatt, 1994
) and autologous buccal mucosa (Lin et al., 2003
). The use of the peritoneum has the disadvantage of being relatively complex and requires the opening of the peritoneal cavity. In addition, the shifting of the labia minor in the vagina has been reported (Karim et al., 1995
). The use of allogenic tissue such as the amnion and allogenic epidermal sheets carries the inherited disadvantage of allograft rejection and the risk of transmission of infective disease. The use of acellular absorbable sheets has recently been attempted in limited series (Jackson and Rosenblatt, 1994
, Motoyama et al., 2003
, Noguchi et al., 2004
) with high success rates. In these cases epithelization occurs from the vaginal vestibule and usually requires several months.
A modified Abbè–McIndoe technique that appears promising is the use of autologous meshed buccal mucosa (Lin et al., 2003
). Disadvantages connected with this technique are the morbidity connected with the removal of the mucosa from the donor site and the relatively long time necessary to achieve a functional vagina. This time period is probably necessary for the meshed mucosa to colonize the entire neovaginal wall.
In the present case, 314 cm2 of in vitro cultured vaginal tissue was used for the epithelization of the canal wall. The decision to adopt the vaginal vestibule as donor site was carried out in order to minimize patient's discomfort and avoid permanent scars. Furthermore, it appeared sensible to carry out an orthotopic transplant as compared with a heterotopic one. Autologous tissue does not carry the risk of infection or allogenic tissue rejection. In addition, in this case, the mould was applied for a reduced time period. We hypothesize that the short time necessary to achieve a normal epithelium was due to the possibility of having enough tissue to cover the entire canal surface. In fact, most techniques, which adopt autologous tissue grafts, adopt mesh of tissue to different ratios before being transplanted. The vaginal mould was adopted in order to maintain in place and to increase the pressure on the gauzes. After removing the mould and gauze, epithelization of the entire canal could be seen throughout the entire neovaginal wall and this suggests that epithelization occurred from the transplanted tissue and not as with other techniques from the vaginal vestibule. Before an attempt was carried out to grow in vitro vaginal tissue in mice (Iguchi et al., 1983), as this was the first case reported in the literature in human, we preferred to maintain a foreign body at night and avoid sexual intercourse for a relatively long time period in order to prevent the formation of a vaginal septum and/or strictures.
This case suggests that autologous in vitro cultured vaginal tissue and successive transplant is feasible and safe. The excellent results obtained by this patient warrant further investigation. In vitro grown vaginal tissue will also serve for other conditions such as vaginal trauma squeal or vaginoplasty in patients' subjected to pelvic exenteration.
| References |
|---|
|
|
|---|
Abbe R. New method of creating a vagina in a case of congenital absence. Med Rec (1898) 54:836–838.
Ashworth MF, Morton KE, Dewhurst J, et al. Vaginoplasty using amnion. Obstet Gynecol (1986) 67:443–446.[Web of Science][Medline]
Baldwin JF. The formation of an artificial vagina by intestinal transplantation. Ann Surg (1904) 40:398.[Medline]
Burger RA, Riedmiller H, Knapstein PG. Ileocecal vaginal construction. Am J Obstet Gynecol (1989) 161:162–167.[Web of Science][Medline]
Carranza-Lira S, Sauer-Ramirez R, Bolivar-Flores YJ. Neovagina with cultured allogenic epidermal sheets. Eur J Obstet Gynecol Reprod Biol (1999) 82:77–79.[CrossRef][Web of Science][Medline]
D'Alberton A, Santi F. Formation of a neovagina by coitus. Obstet Gynecol (1972) 40:763–764.[Web of Science][Medline]
Davydov SN, Zhvitiashvili OD. Formation of vagina (colpoiesis) from peritoneum of Douglas pouch. Acta Chir Plast (1974) 16:35–41.[Web of Science][Medline]
Dhall K. Amnion graft for the treatment of congenital absence of the vagina. Br J Obstet Gynaecol (1984) 91:279–282.[Web of Science][Medline]
Edmonds DK. Vaginal and uterine anomalies in the paediatric and adolescent patient. Curr Opin Obstet Gynecol (2001) 13:463–467.[CrossRef][Web of Science][Medline]
Fedele L, Busacca M, Candiani M, et al. Laparoscopic creation of a neovagina in Mayer Rokitansky Küster Hauser syndrome by modification of Vecchietti operation. Am J Obstet Gynecol (1994) 171:268–269.[Web of Science][Medline]
Frank RT. The formation of an artificial vagina without operation. Am J Obstet Gynecol (1938) 135:1053–1055.
Hauser GA, Schreiner WE. The Mayer Rokitansky Küster syndrome. Schwiez Med Wochenschr (1961) 91:381–384.
Hendren WH, Atala A. Use of bowel for vaginal reconstruction. J Urol (1994) 152:752–755.[Web of Science][Medline]
Iguchi T, Uchima FD, et al. Growth of normal mouse vaginal epithelial cells in and on collagen gels. Proc Natl Acad Sci USA (1983) 80:3743–3747.
Jackson ND, Rosenblatt PL. Use of Interceed absorbable adhesion barrier for vaginoplasty. Obstet Gynecol (1994) 84:1048–1050.[Web of Science][Medline]
Karim RB, Hage JJ, Dekker JJ, et al. Evolution of the methods of neovaginoplasty for vaginal aplasia. Eur J Obstet Gynecol Reprod Biol (1995) 58:19–27.[CrossRef][Web of Science][Medline]
Küster H. Uterus bipartitus solidus rudimentarius cum vagina solida. Z Geb Gyn (1910) 67:692.
Lin WC, Chang CY, Shen YY, et al. Use of autologous buccal mucosa for vaginoplasty: a study of eight cases. Hum Reprod (2003) 18:604–607.
Mayer CAJ. Uber verdoppelungen des uterus und ihre arten, nebst bemerkungen uber hasenscharte ind wolfsrachen. J Chir Auger (1829) 13:525.
McIndoe AH, Banniser JB. An operation for the cure of congenital absence of the vagina. J Obstet Gynaecol Br Emp (1938) 45:490–494.
Motoyama S, Laoag-Fernandez JB, Mochizuki S, et al. Vaginoplasty with Interceed absorbable adhesion barrier for complete squamous epithelialization in vaginal agenesis. Am J Obstet Gynecol (2003) 188:1260–1264.[CrossRef][Web of Science][Medline]
Noguchi S, Nakatsuka M, Sugiyama Y, et al. Use of artificial dermis and recombinant basic fibroblast growth factor for creating a neovagina in a patient with Mayer-Rokitansky-Küster-Hauser syndrome. Hum Reprod (2004) 19:1629–1632.
Roberts CP, Haber MJ, Rock JA. Vaginal creation for mullerian agenesis. Am J Obstet Gynecol (2001) 185:1349–1353.[CrossRef][Web of Science][Medline]
Rock JA, Azziz R. Genital anomalies in childhood. Clin Obstet Gynecol (1987) 30:682–696.[CrossRef][Web of Science][Medline]
von Rokitansky KF. Uber die sogenannten verdoppelungen des uterus. Med Jb Ost Staat (1938) 26:39.
Rothman D. The use of peritoneum in the construction of a vagina. Obstet Gynecol (1972) 40:835–838.[Web of Science][Medline]
Schmid-Tannwald I, Hauser GA. Atypical forms of the Mayer–Rokitansky–Kuester syndrome. Geburtshilfe Frauenheilkd (1977) 37:386–392.[Medline]
Templeman C, Hertweck SP. Vaginal agenesis: an opinion on the surgical management. J Pediatr Adolesc Gynecol (2000) 13:143–144.[CrossRef][Medline]
Templeman CL, Hertweck SP, Levine RL, Reich H. Use of laparoscopically mobilized peritoneum in the creation of a neovagina. Fertil Steril (1977) 74:589–592. (2000).[CrossRef]
Vecchietti G. Creation of an artificial vagina in Rokitansky Küster Hauser syndrome. Attual Ostet Ginecol (1965) 11:131–147.[Medline]
Williams EA. Congenital absence of the vagina ± a simple operation for its relief. J Obstet Gynaecol Br Comm (1964) 71:511–516.[Web of Science][Medline]
Submitted on November 9, 2006; resubmitted on January 30, 2007; accepted on February 5, 2007.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L Trommelmans, J Selling, and K Dierickx Ethical reflections on clinical trials with human tissue engineered products J. Med. Ethics, September 1, 2008; 34(9): e1 - e1. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




